SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / SPON ADS NEW
Total 13F shares
388,321
Share change
+146,526
Total reported value
$838,879
Price per share
$2.16
Number of holders
10
Value change
+$302,473
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 09073Q204?
CUSIP 09073Q204 identifies SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) as of Q1 2023

As of 31 Mar 2023, SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 388,321 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Virtu Financial LLC, UBS Group AG, MORGAN STANLEY, Credit Agricole S A, Aspire Private Capital, LLC, Global Retirement Partners, LLC, WELLS FARGO & COMPANY/MN, and NewSquare Capital LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.